Vietnam Institute Seeks Human Trials On Bird-Flu Vaccine
This article was originally published in PharmAsia News
A health institute has applied to Vietnam's Health Ministry to be allowed to begin human trials on an avian-influenza vaccine it has developed. The Nha Trang Institute of Vaccines and Medical Biological said it is ready for human trials following successful tests of the vaccine on animals. Backed by World Health Organization funds, the institute is building a plant capable of producing as many as a million doses of vaccine a year. A separate bird-flu trial has been testing a vaccine on Vietnamese military volunteers. (Click here for more
You may also be interested in...
Procter & Gamble, through its UK wellness subsidiary Nature's Best, is on-trend with new vegan vitamin D3 and iron supplements. Nature's Best has also launched three other vitamin D3 products in the country, as well as an ashwagandha supplement.
The MHRA has updated its guidance on regulatory flexibilities for medical devices and medicinal products resulting from COVID-19 to highlight how its approach differs from the EU.
The Swiss company is planning a US trial of CBSO, the first transcatheter septal occluder with a bioresorbable, metal-free frame.